See every company, program, and investor in your defined market, plus the trends and issues shaping where it goes next.
Build a refined target list from the full biopharma universe, then size up each partner's pipeline, funding, deals, and strategy before you meet.
Track rival targets, compounds, dealmaking, and fundraising, with automated alerts the moment something changes in your space.
Find comparable programs, review the investing and partnering deals in your space, and see exactly where your program fits in the industry pipeline.
Every company, product, disease, and deal links straight to expert analysis. No data mining or cleaning required, and no extra headcount.
Forward-looking analysis across science, capital, and policy, from analysts who dissect the latest trends so you can position your company for change.
A curated database with linked profiles on companies, diseases, products, deals, targets, and investors, including financing histories and deal terms.
Find novel or untapped targets, build a competitive landscape for any target, and filter products by therapeutic modality, from all RNA down to mRNA.
Analyst briefs on early-stage science plus custom alerts that track pipelines and competitive moves for you.
A customizable portal to filter BioCentury's business and financial intelligence to your exact needs, with mobile-friendly profiles for meetings and conferences.
Meet the executives and investors you need for funding, partnerships, and advice at BioCentury's global networking events.
"When it comes to timely, relevant discussion of complex industry issues, BioCentury provides fact-based, in-depth reporting and analysis, resisting sensationalism and often incorporating multiple perspectives. This allows us as readers to walk away informed, and in some cases, with actionable insights."
"The quality and depth of BioCentury's reporting and analysis sets them apart from their competitors. BioCentury provides the most intelligent coverage of the pharma and biotech industry."
BioCentury is built for biopharma innovators and investors: executives, business development and strategy teams, R&D leaders, and investors who need to make financing, investing, and dealmaking decisions with confidence.
BCIQ is BioCentury's drug discovery and development database, designed and curated by BioCentury's industry experts and data team. It connects profiles on companies, diseases, products, deals, and targets, and links each one to related BioCentury analysis.
Only BCIQ provides direct links from company, product, disease, and deal data to insights from BioCentury's analysts. You get answers and context, not just numbers, with no data mining or cleaning required.
Yes. You can set automated alerts for product and strategic developments at competing companies, and monitor targets, dealmaking, and fundraising in your therapeutic and technology spaces.
BCIQ covers biotech and biopharma companies, products, diseases, deals, targets, therapeutic modalities, and financings. BioCentury publishes clear coverage levels for each area (comprehensive, focused, or basic) so you always know what to expect.
You connect with one of BioCentury's product experts, get a guided tour, and explore the platform's analysis and data for yourself.
Schedule your call today and see what's next in biopharma innovation.